Xiaoling Xu
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 29, 2025
RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion.Shiqi Lin, Dongyang Tang, Josh Haipeng Lei
|Mar 29, 2025
Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy.Lihua Mo, Min Deng, Ragini Adhav
|Mar 19, 2022
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.Jianjie Li, Xiaodong Shu, Jun Xu
|May 25, 2021
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.Ren-Bo Ding, Ping Chen, Barani Kumar Rajendran
|Sep 26, 2020
Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor.Jianlin Liu, Ragini Adhav, Kai Miao
|Jun 28, 2020
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.Kai Miao, Josh Haipeng Lei, Monica Vishnu Valecha
Pageof 1
Frequent Collaborators
5 joint publications
Chuxia Deng
4 joint publications
Kai Miao
2 joint publications
Jianming Zeng
2 joint publications
Koon Ho Wong
2 joint publications
Josh Haipeng Lei
1 joint publications
Ada Hang-Heng Wong
1 joint publications
Joong Sup Shim
1 joint publications
Yuni Chan
1 joint publications
Lin Chen
1 joint publications
Ning-Yi Shao
